US 9205091
Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
granted A61KA61K31/4965A61K31/551
Quick answer
US patent 9205091 (Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/4965, A61K31/551, A61P, A61P35/00